| Literature DB >> 28529499 |
Lewan Parker1, Christopher S Shaw2, Nigel K Stepto1,3,4, Itamar Levinger1,4.
Abstract
Physical inactivity, excess energy consumption, and obesity are associated with elevated systemic oxidative stress and the sustained activation of redox-sensitive stress-activated protein kinase (SAPK) and mitogen-activated protein kinase signaling pathways. Sustained SAPK activation leads to aberrant insulin signaling, impaired glycemic control, and the development and progression of cardiometabolic disease. Paradoxically, acute exercise transiently increases oxidative stress and SAPK signaling, yet postexercise glycemic control and skeletal muscle function are enhanced. Furthermore, regular exercise leads to the upregulation of antioxidant defense, which likely assists in the mitigation of chronic oxidative stress-associated disease. In this review, we explore the complex spatiotemporal interplay between exercise, oxidative stress, and glycemic control, and highlight exercise-induced reactive oxygen species and redox-sensitive protein signaling as important regulators of glucose homeostasis.Entities:
Keywords: exercise; glycemic control; insulin signaling; oxidative stress; redox; stress kinase
Year: 2017 PMID: 28529499 PMCID: PMC5418238 DOI: 10.3389/fendo.2017.00087
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Primary signaling pathways involved in insulin-stimulated glucose uptake. Akt, protein kinase B; AS160, Akt substrate of 160 kDa; GLUT4, glucose transporter 4; GSK3, glycogen synthase kinase 3; IRS-1/2, insulin receptor substrates 1 and 2; mTORC1/2, mechanistic target of rapamycin complex 1/2; PDK1, phosphoinositide-dependent kinase-1; PI3K, phosphatidylinositol-3 kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKC, protein kinase C; PP2A, protein phosphatase 2; PTEN, phosphatase and tensin homolog; PTP1B, protein tyrosine phosphatase 1B.
Figure 2Primary signaling pathways involved in contraction-induced glucose uptake. AMPK, 5′ adenosine monophosphate-activated protein kinase; AS160, Akt substrate of 160 kDa; CaMK, Ca2+/calmodulin-dependent protein kinase; GLUT4, glucose transporter 4; PKC, protein kinase C; RAC1, ras-related C3 botulinum toxin substrate 1.
Figure 3Sources of ROS in skeletal muscle. ETC, electron transport chain; eNOS, endothelial nitric oxide synthase; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; ONOO−, peroxynitrite; OH, hydroxyl radical; , superoxide; H2O2, hydrogen peroxide; H2O, water; EcSOD, extracellular superoxide dismutase; MnSOD, manganese superoxide dismutase; CuZuSOD, copper–zinc superoxide dismutase; GPx, glutathione peroxidase; CAT, catalase; PLA2, phospholipase A2; Fe, iron; ROS, reactive oxygen species. Adapted from the study by Powers and Jackson (93) with permission.
Figure 4The influence of oxidative stress in health and disease. p38, p38 mitogen-activated protein kinases; JNK, c-Jun N-terminal kinases; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells.
Summary of key findings from research investigating the effect of redox state manipulation on acute exercise-induced protein signaling and molecular markers of skeletal muscle adaptation.
| Reference | Participants | Exercise | Redox manipulation | Time point | SAPK signaling | Markers of skeletal muscle adaptation |
|---|---|---|---|---|---|---|
| Gomez-Cabrera et al. ( | 25 adults | Marathon | Allopurinol ( | Postex. | Placebo only: ↑ lymphocyte NF-κB p50 activity | |
| Gomez-Cabrera et al. ( | 15 male Wistar rats | Exhaustive treadmill exercise | Rest ( | Postex. | Placebo only: ↑ p-p38 MAPK, NF-κB activity | Placebo only: ↑ MnSOD, iNOS, and eNOS mRNA |
| Henriquez-Olguin et al. ( | 20 male BalbC mice | Swimming exercise | Apocynin ( | Postex. | Apocynin: attenuated p-p38 MAPK and p-NF-κB p65 | Apocynin: attenuated MnSOD, GPX, CS, and mtTFA mRNA |
| Kang et al. ( | 18 female Sprague-Dawley rats | Exhaustive treadmill exercise | Allopurinol ( | Postex. | Allopurinol: attenuated p–p38 MAPK, p-IκBα, NF-κB DNA binding | Allopurinol: attenuated PGC-1α, p-CREB, NRF-1, mtTFA content |
| Michailidis et al. ( | 10 young males | 300 unilateral eccentric leg repetitions | Crossover: | 2 h postex. | Both: ↑ p-p38 MAPK | Both: ↑ p-AktSer473, p–p70S6KThr389 and p-rpS6. NC MyoD. Muscle function impaired (mean torque) |
| NC p-NF-κB p65 | ||||||
| 2 days postex. | NAC: greater p-p38 MAPK | Both: ↑ p-AktSer473. NC MyoD. NAC: attenuated mTORSer2448, p-p70S6KThr389 and p-rpS6. Muscle function impaired. | ||||
| 8 days postex. | Both: NC p-NF-κB p65 | NAC: attenuated p-AktSer473, mTORSer2448, p-p70S6KThr389, p-rpS6, and MyoD | ||||
| Petersen et al. ( | 8 young males | 45 min at 71% VO2peak followed by 92% VO2peak to fatigue | Crossover: | Postex. (45 min at 71% VO2peak) | Both: ↑ p-p38 MAPK, ↓ IκBα. NC p-NF-κB p65. NAC: attenuated p-JNK | Both: ↑ PGC-1 α mRNA. NAC: attenuated MnSOD mRNA |
| Postex. (fatigue) | NAC: attenuated p-JNK, ↓ p-NF-κB p65. | Both: NC PGC-1 α mRNA and MnSOD mRNA | ||||
| Strobel et al. ( | Male Wistar rats | Exhaustive treadmill exercise | DEM and controls | Postex. | Both ↑ p-p38 MAPK | Not measured |
| Trewin et al. ( | 7 young adults | 55 min at 65% VO2peak followed by 5 min at 85% VO2peak | Crossover: | Postex. | NAC: ↓ p-p38 MAPK | Both: ↑ p-p70S6KThr389 and p-rpS6 |
| Wadley et al. ( | Male Sprague-Dawley rats | Treadmill exercise | Allopurinol or placebo | Postex. | Allopurinol: attenuated p–p38 MAPK | Not measured |
.
NC, no change compared to baseline or control; ↑, significant increase compared to baseline or control; ↓, significant decrease compared to baseline or control; iNOS, inducible nitric oxide synthase; eNOS, endothelial nitric oxide synthase; CS, citrate synthase; mtTFA, mitochondrial transcription factor A; NRF-1/2, nuclear respiratory factor-1 and 2; MyoD, myogenic determination factor; PGC-1 α, peroxisome proliferator-activated receptor gamma coactivator 1 α; young, participants 18–40 years old; middle aged, 40–65 years old; older, >65 years old; active, recreationally active; GPx, glutathione peroxidase; MnSOD, manganese superoxide dismutase; EcSOD, extracellular superoxide dismutase; MAPK, mitogen-activated protein kinase; DEM, diethyl maleate; SAPK, stress-activated protein kinase; IκBα, nuclear factor of kappa light polypeptide gene enhancer in β-cells inhibitor alpha.
Figure 5Primary ROS signaling pathways involved in positive and negative regulation of insulin signaling. 4-HNE, 4-hydroxynonenal; Akt, protein kinase B; AS160, Akt substrate of 160 kDa; GSK3, glycogen synthase kinase 3; IRS-1/2, insulin receptor substrates 1 and 2; JNK, c-Jun N-terminal kinases; mTORC2, mechanistic target of rapamycin complex 2; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NOX, nicotinamide adenine dinucleotide phosphate oxidase; P38 MAPK, p38 mitogen-activated protein kinases; PDK1, phosphoinositide-dependent kinase-1; PI3K, phosphatidylinositol-3 kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKC, protein kinase C; PP2A, protein phosphatase 2; PTEN, phosphatase and tensin homolog; PTP1B, protein tyrosine phosphatase 1B; ROS, reactive oxygen species.
Summary of key findings from research investigating exercise, redox state, and enhancement of glycemic control.
| Reference | Participants/animals/cells | Exercise stimulus | Redox manipulation | Time point/conditions | SAPK signaling | Glycemic control |
|---|---|---|---|---|---|---|
| Berdichevsky et al. ( | Myocytes, myoblasts, and/or myotubes | Acute oxidative stress (simulated exercise) | Chronic oxidative stress | Chronic oxidative stress | ↑ p-JNK | ↓ p-AktSer473,Thr308. ↓ glucose uptake |
| Castorena et al. ( | Low-fat and high-fat diet fed rats | Swimming exercise | 3 h postex. + Ins. | NC p-JNK | NC AktSer473,Thr308, IRTyr1162/1163, IRS-1-PI3K | |
| Geiger et al. ( | Male Wistar rats | p-p38MAPK inhibition | 3 h postcontraction | ↑ p-p38 MAPK | Not measured | |
| Higashida et al. ( | Male Wistar rats | 3-day swimming program or 3 weeks, 6 days/week swimming program | Vehicle or vitamin C + E supplementation | Post 3-day training | 3-day and 3-week training: vitamin C + E: similar ↑ in measures of mitochondrial protein content, ↑ GLUT4, ↑ glucose uptake | |
| Loh et al. ( | 10 wild-type mice9 GPx1−/− mice | Treadmill exercise | GPx1−/− and | Postex. + Ins. | GPx1−/− mice: similar insulin sensitivity | |
| Parker et al. ( | 8 young adults | Crossover design | Postex. | All ex.: similar ↑ p-JNK, ↑ p-p38 MAPK, ↓ IκBα; SIE: ↑ p-NF-κB; CMIE and HIIE: NC p-NF-κB | All ex.: NC IRS-1, similar ↓ p-AktSer473; SIE: ↑ p-IRS1Ser307, greatest ↓ p-AS160Ser588; HIIE: greatest ↑ p-IRS1Ser307, ↓ p-AS160Ser588; CMIE: ↑ p-IRS1Ser307, NC p-AS160Ser588 | |
| Parker et al. ( | 11 middle-aged males | Cycling exercise: HIIE: (4 × 4 min at 95% HRpeak; 2-min recovery periods) | Rest trial: 2 h post-Ins. | ↑ p-JNK, ↑ p-p38 MAPK, ↓ IκBα | ↑ p-IRS1Ser307, ↑ p-AS160Ser588, Ser318 | |
| Picklo and Thyfault ( | 56 high-fat diet-induced obese Sprague-Dawley rats | Motorized wheel exercise. 12 weeks, 5 times per week | With and without vitamin C + E supplementation | Posttraining | Vitamin C + E: similar improvement in HOMA-IR and OGTT | |
| Ristow et al. ( | 40 young males (20 trained and 20 active) | Biking, running and circuit training. 4 weeks, 5 times per week | Placebo or vitamin C + E supplementation | Posttraining | Vitamin C + E: attenuated ↑ insulin sensitivity, mRNA expression of PPARγ, PGC-1α/β | |
| Ropelle et al. ( | Male Wistar rats | Swimming exercise | 16 h postex. + Ins. | Compared to control: obese: ↑ p-JNK, ↓ IκBα | Compared to both control and obese + Ex.: obese attenuated insulin sensitivity, PI3K, p-IRS-1/2, p-IR. ↑ PTP1B content/activity and p-IRSSer312 | |
| Somwar et al. ( | Male Wistar rats | p-p38 MAPK inhibition | Post-Ins. | ↑ p-p38 MAPK and activity | Not measured | |
| Thong et al. ( | 7 young males | 60 min of one-legged knee extension | 3 h postex. | ↑ p-p38 MAPK | Not measured | |
| Trewin et al. ( | 7 young adults | 55 min cycling at 65% VO2peak followed by 5 min at 85% VO2peak | Crossover: | Postex. | NAC: ↓ p-p38 MAPK | Both: NC p-AktThr308,Ser473, ↑ p-PAS160 |
| Yfanti et al. ( | 21 young males | Intense endurance training program | Placebo or vitamin C and E supplementation | Posttraining | Vitamin C + E: similar ↑ insulin sensitivity, ↑ Akt, ↑ HXK2, ↑ GLUT4 | |
.
Ins., insulin stimulation; NC, no change compared to baseline or control; ↑, significant increase compared to baseline or control; ↓, significant decrease compared to baseline or control; Akt, protein kinase B; AS160, Akt substrate of 160 kDa; CMIE, continuous moderate-intensity exercise; GLUT4, glucose transporter type 4; GSK3, glycogen synthase kinase 3; HIIE, high-intensity interval exercise; HOMA-IR, homeostatic model assessment for insulin resistance; HXK2, hexokinase II; IRS-1/2, insulin receptor substrates 1 and 2; JNK, c-Jun N-terminal kinases; NAC, n-acetylcysteine; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; P38 MAPK, p38 mitogen-activated protein kinases; PI3K, phosphatidylinositol-3 kinase; PPARγ/α/β, peroxisome-proliferator-activated receptor gamma/alpha/beta; PTP1B, protein tyrosine phosphatase 1B; SIE, sprint interval exercise; SAPK, stress-activated protein kinase.
Figure 6Primary signaling pathways involved in contraction and insulin-stimulated glucose uptake and the potential role of ROS. 4-HNE, 4-hydroxynonenal; Akt, protein kinase B; AMPK, 5′ adenosine monophosphate-activated protein kinase; AS160, Akt substrate of 160 kDa; CaMK, Ca2+/calmodulin-dependent protein kinase; GLUT4, glucose transporter 4; GSK3, glycogen synthase kinase 3; IRS-1/2, insulin receptor substrates 1 and 2; JNK, c-Jun N-terminal kinases; mTORC2, mechanistic target of rapamycin complex 2; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NOX, nicotinamide adenine dinucleotide phosphate oxidase; P38 MAPK, p38 mitogen-activated protein kinases; PDK1, phosphoinositide-dependent kinase-1; PI3K, phosphatidylinositol-3 kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKC, protein kinase C; PP2A, protein phosphatase 2; PTEN, phosphatase and tensin homolog; PTP1B, protein tyrosine phosphatase 1B; RAC1, ras-related C3 botulinum toxin substrate 1; ROS, reactive oxygen species.